SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
139Omeros Ophthalmology Product OMS302 Granted Eligibility for European CentralizedHoward Williams-4/30/2013
138<<<<< reaffirming our Strong Buy recommendation of OMER and contiSteve Lokness-4/18/2013
137WBB Securities issued an updated, strongly positive research report on OMER todaHoward Williams-4/18/2013
136Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Howard Williams-4/17/2013
135OMER's largest institutional shareholder according to Yahoo finance is IngalHoward Williams-4/11/2013
134One of the strongest GPCR-related PRs I recall seeing from OMER ****************Howard Williams-4/10/2013
133 Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction -- Clinical EntHoward Williams-3/19/2013
132 Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference Howard Williams-3/1/2013
131http://investor.omeros.com/phoenix.zhtm … highlight= Omeros Announces ToxicologHoward Williams-2/7/2013
130Omeros Identifies Small Molecules for Class B GPCR http://investor.omeros.com/pHoward Williams-1/16/2013
129Per an OMER Form 4 just out, Director Peter Demopulos bought 9,345 OMER shares oHoward Williams-1/3/2013
128Interesting ....... Matt Schilling's "short and distort" SeekingAlHoward Williams-12/31/2012
127An OMER shorter, Matt Schilling, has penned a piece on SeekingAlpha with factualHoward Williams-12/30/2012
126Wedbush Says Buy Omeros (OMER) on Weakness from Mixed OMS103HP Phase 3 Results Howard Williams-12/29/2012
125Friday buy ratings and price targets .... In a report published Friday, DeutschHoward Williams-12/29/2012
124A positive spin on less-than-hoped-for results (conf call at 5 PM EST today) htHoward Williams-12/27/2012
123OMER mentioned in Elemer Piros interview At the end of ..... http://jutiagroupHoward Williams212/14/2012
122OMER is clearly making every effort to keep the market informed, including positHoward Williams-12/6/2012
121SEATTLE, Nov. 29, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinHoward Williams-11/29/2012
120SEATTLE, Nov. 20, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopHoward Williams-11/20/2012
119GPR17-Targeting Compounds Identified by Omeros Promote Myelination -RemyelinatioHoward Williams-11/15/2012
118An excerpt from ..... Four Under the Radar Biotechnology Stocks that Could RaHoward Williams-11/11/2012
117SEATTLE, Nov. 8, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reHoward Williams-11/8/2012
116Omeros' Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical THoward Williams-11/5/2012
115Omeros Corporation : Omeros Announces Enrollment in Phase 1 Clinical Trial EvaluHoward Williams-11/1/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News